BRAIN BIOTEC NA O.N./ DE0005203947 /
2024-09-05 5:36:02 PM | Chg. -0.120 | Volume | Bid2024-09-05 | Ask2024-09-05 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1.590EUR | -7.02% | 29,944 Turnover: 47,171.510 |
-Bid Size: - | -Ask Size: - | 33.3 mill.EUR | 0.00% | - |
Assets
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 7.6000 | 12 | 17.1000 | 24.5000 | 24.3000 | ||||||
Intangible Assets | 7.1000 | 19.1000 | 15.8000 | 13.3000 | 13.5000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 14.9000 | 33.4000 | 35.2000 | 39.1000 | 38.6000 | ||||||
Inventories | 7.2000 | 8 | 8 | 7 | 7 | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 39 | 25.5000 | 15.2000 | 18.9000 | 24.5000 | ||||||
Current Assets | 53.6000 | 41 | 31 | 33.1000 | 39.1000 | ||||||
Total Assets | 68.5000 | 74.5000 | 66.1000 | 72.2000 | 77.7000 |
Liabilities
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 2.4000 | 2.9000 | 4.4000 | 3.2000 | 3.8000 | ||||||
Long-term debt | 8.2000 | 25.4000 | 24.8000 | 27.3000 | 17.7000 | ||||||
Liabilities to Banks | 9.7000 | 27.8000 | 28.4000 | 30.6000 | 20.3000 | ||||||
Provisions | 2.4000 | 4.3000 | 7.2000 | 5 | 5.1000 | ||||||
Liabilities | 21.1000 | 43.9000 | 49.1000 | 46.1000 | 35.9000 | ||||||
Share Capital | 18.0560 | 18.0560 | 18.0560 | 19.8610 | 21.8470 | ||||||
Total Equity | 47.2000 | 25.8000 | 12.2000 | 20.8000 | 38.8000 | ||||||
Minority Interests | .2000 | 4.9000 | 4.9000 | 5.4000 | 3 | ||||||
Total liabilities equity | 68.5000 | 74.5000 | 66.1000 | 72.2000 | 77.7000 |
Income Statement
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 26.9000 | 30.5000 | 41.2000 | 39.2000 | 40.7000 | ||||||
Depreciation (total) | 1.7000 | 3 | 4.7000 | 4.4000 | 4 | ||||||
Operating Result | -9.4000 | -9.7000 | -7.2000 | -8.2000 | -6.5000 | ||||||
Interest Income | 0.0000 | 1.3000 | -1.6000 | .6000 | 4 | ||||||
Income Before Taxes | -9.4000 | -8.5000 | -10.5000 | -9.9000 | -4.3000 | ||||||
Income Taxes | -.3000 | .2000 | -.0090 | -.9000 | .4000 | ||||||
Minority Interests Profit | -.0600 | -.2000 | -.0200 | -.7000 | -.3000 | ||||||
Net Income | -9.6000 | -8.1000 | -10.5000 | -9.7000 | -5 |
Per Share
Cash Flow
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -5.8000 | -5.4000 | -3.4000 | -4.8000 | -3.9000 | ||||||
Cash Flow from Investing Activities | 8.8000 | -12.6000 | -6.7000 | -4.5000 | -2.2000 | ||||||
Cash Flow from Financing | 27.7000 | 4.7000 | -.3000 | 13.1000 | 11.6000 | ||||||
Decrease / Increase in Cash | 30.7000 | -13.4000 | -10.4000 | 3.9000 | 5.5000 | ||||||
Employees | 212 | 247 | 281 | 279 | 288 |